Company Overview:
Contineum Therapeutics (Nasdaq: CTNM) is a clinical-stage biopharmaceutical company pioneering novel, oral small molecule therapies for NI&I indications with significant unmet need. Contineum is advancing a pipeline of internally-developed programs with multiple drug candidates now in clinical trials. PIPE-791 is an LPA1 receptor antagonist in clinical development for idiopathic pulmonary fibrosis and chronic pain. PIPE-307 is a selective inhibitor of the M1 receptor in clinical development for relapsing-remitting multiple sclerosis and major depressive disorder. For more information, please visit www.contineum-tx.com.
Job Summary:
The in vivo biology group at Contineum Therapeutics is currently seeking an energetic Sr. Scientist to join our drug discovery team in San Diego. This is a hands-on, laboratory position with responsibilities involving focused conceptualization and execution of in vivo studies to evaluate drug candidates. Studies may encompass a range of neuroscience, immunology, and inflammatory (NI&I) conditions, including but not limited to neurodegeneration, peripheral neuropathies, and fibrosis. The successful candidate will have expertise in all aspects of in vivo pharmacology and biology and be a strong team player who is scientifically curious, enjoys the process of scientific discovery, and can communicate well in an interdisciplinary environment.
This role is office-based in San Diego, CA and relocation is not provided.
Key Responsibilities:
Requirements
Benefits
We offer a competitive total compensation package, as well as working in a supportive team environment. The anticipated salary range for candidates is $138,000- $145,000. The final salary offered to a successful candidate will be dependent on several factors that may include but are not limited to the type and length of experience within the job, type and length of experience within the industry, education, etc.
Contineum offers competitive compensation and benefits, including: